BRIEF-Adocia and Lilly initiate phase 1b study evaluating BioChaperone Lispro

* Adocia and Eli Lilly and Company initiate a phase 1b study evaluating ultra-rapid BioChaperone Lispro in patients with type 1 diabetes using insulin pump therapy
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.